Compare Eaton Corporation plc (ETN) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eaton Corporation plc vs Novartis AG — how do they compare? Eaton Corporation plc trades at $463.5 (market cap $172.82B), while Novartis AG trades at $153.53 (market cap $298.18B). The key difference: Novartis AG is the larger of the two by market cap, and Novartis AG pays the higher dividend (3.02%). Which is the better fit depends on your goals.
| ETN | NVS | |
|---|---|---|
Market Cap | $172.82B | $298.18B |
Sector | Technology | Health |
52-Week High | $459.29 | $168.62 |
52-Week Low | $315.82 | $119.31 |
Enterprise Value | $193.45B | $339.50B |
Dividend Yield | 0.99% | 3.02% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eaton (ETN) trades at $448.68, up 0.11% on the day and near its 52-week high, supported by a bullish technical trend and strong fundamental performance. The company reported three consecutive quarterly earnings beats, with Q2 2026 EPS of $3.15 exceeding the $3.07 estimate, and raised its full-year outlook. Revenue growth is robust, driven by surging demand in electrical and aerospace segments, particularly from data center expansion.
The outlook remains positive given raised guidance and analyst consensus, but the stock's premium valuation (P/E of 45.31) poses a risk if growth moderates. Key opportunities include exposure to AI-driven power infrastructure spending, while risks involve execution challenges and macroeconomic sensitivity. The consensus price target of $496.50 implies ~11% upside from current levels.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eaton Corporation plc
Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.
Read more on ETN →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
